2026 Update: Wegovy & Zepbound Prices What Patients Need to Know
Feb 06, 20262026 Update: Wegovy & Zepbound Prices What Patients Need to Know
If you’re exploring prescription options for medically supported weight loss, Wegovy (semaglutide) and Zepbound (tirzepatide) remain two of the most effective GLP-1 medications available.
We know cost and access are top concerns for patients so here’s the latest pricing information and how you can obtain these medications in 2026.
Current Price Landscape
Brand-name GLP-1 medications once carried list prices well over $1,000 per month, but major changes in pricing have taken place. Both Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) have lowered direct prices significantly, and there are new programs that make them more affordable for people without insurance coverage.
Wegovy (semaglutide)
-
Direct self-pay pricing through manufacturer programs is often around $349/month after initial starter pricing.
-
Novo sometimes offers starter doses as low as $199/month for the first fills.
-
If you pay full list price without discounts, some guides still list prices above $1,300/month though these high prices are now much less common due to discount programs and negotiated deals.
Zepbound (tirzepatide)
-
Cash-pay pricing generally ranges from $299 to around $449/month depending on dose and program used.
-
Some manufacturer cost support programs keep the monthly price around the same as Wegovy once the dose increases.
-
List prices for name-brand Zepbound can still be above $1,000/month in the absence of discount programs, but most patients won’t see these higher prices thanks to recent pricing reforms.
💡 These price ranges reflect direct purchase options when patients pay out of pocket. Actual costs vary widely depending on insurance coverage, pharmacy, dose, and available manufacturer programs.
How Patients Can Access These Medications
Here are the most common methods patients are using in 2026 to access Wegovy and Zepbound:
1. Through Your Doctor + Insurance
-
Many commercial health plans now cover GLP-1 medications to varying degrees, including Wegovy and Zepbound. Copays with coverage can be as low as $0–$25/month with manufacturer savings cards.
-
Coverage is still inconsistent across plans, and Medicare coverage for weight loss prescriptions is limited though evolving with federal policy changes.
2. Manufacturer Self-Pay Programs
-
Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) both offer direct purchasing programs that reduce cost for uninsured or cash-pay patients.
-
These programs often deliver medications by mail and require a valid prescription from your clinician.
3. Third-Party Programs & Telehealth Prescribers
-
Some telehealth providers and compassionate programs offer Wegovy or Zepbound with pricing that can be competitive with direct manufacturer offers or through a membership model.
4. Copay Cards & Patient Assistance Programs
-
Manufacturer savings cards may reduce out-of-pocket costs significantly for patients with commercial insurance, though terms vary by plan and change year-to-year.
Our Mission
At LaRocca Medical, we treat every patient with personalized care because healthcare is never one-size-fits-all.
Medications like Wegovy and Zepbound can be powerful tools, but understanding costs, access options, and whether they truly fit your health goals matters just as much as the prescription itself.
We take the time to help patients navigate insurance coverage, self-pay programs, and manufacturer pricing so there are no surprises.
Our focus is on sustainable, medically appropriate care that supports your long-term health not quick fixes.
If you’d like guidance on current pricing, insurance options, or determining which medication may be right for you, our team is here to walk with you every step of the way.
